Sponsor Pipeline

Dai, Guanghai Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 2
3
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06685276 Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later… Colorectal Cancer Metastatic Recruiting
NCT06708858 Phase Ⅱ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus… Advanced Biliary Tract Cancer Recruiting
NCT07392346 Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab… Gastric Cancer Adenocarcinoma Metastatic Recruiting
Phase 1/2
NCT06782685 Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV Advanced Pancreatic Cancer (Part 1) Recruiting
Disease Areas
Colorectal Cancer (1) Cholangiocarcinoma (1) Pancreatic Cancer (1) Gastric Cancer (1)
Get alerts when Dai, Guanghai's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free